|
|
Continuum,
October 2006,
Volume 12,
Issue 5
| Key Points for Issue. (pdf) |
|
faculty.
(PDF only)
|
|
editor's preface.
- Miller, Aaron
|
|
introduction.
- Bourgeois, James
|
|
diagnosis and management of delirium.
- Bourgeois, James, Seritan, Andreea
>
Show/Hide Abstract
Delirium is an acute- to subacute-onset impairment in cognitive and other psychiatric functions due to central nervous system (CNS) and/or systemic disturbances. Thorough evaluation, accurate diagnosis, and thoughtful nonpharmacological and pharmacological management are necessary to reduce morbidity and improve prognosis. Due to premorbid CNS illness, neurological patients are exquisitely vulnerable to delirium. In addition, several groups of medications used for neurological illness predispose patients to delirium. Recent literature provides additional insights into the genesis, diagnosis, classification, and management of delirium. Confident management of delirium is essential to modern psychiatric and neurological practice.(C) 2006 American Academy of Neurology
|
|
psychopharmacology for neurologists: principles of diagnosis and medication selection.
- Hilty, Donald, Seritan, Andreea, McCarron, Robert, Boland, Robert
>
Show/Hide Abstract
Patients with neurological disorders commonly have mood, anxiety, and psychotic disorders. These disorders may have multiple biological underpinnings and worsen over time without treatment. Early diagnosis and biopsychosocial treatment, integrating medical and psychiatric interventions, are highly desirable. Medications have a major role in treatment, although caution must be exercised in terms of potential side effects. Tables compare medications and offer step-by-step approaches and guidelines for the neurologist. Psychiatric consultation and/or management may be required for urgent or severe cases.(C) 2006 American Academy of Neurology
|
|
autism-presentation, diagnosis, and management.
- Sugden, Steven, Corbett, Blythe
>
Show/Hide Abstract
Autism spectrum disorders (ASDs) represent a cluster of symptoms with core deficits in social, communication, and behavioral domains, which develop by the age of 3. Recent epidemiological reports estimate the overall prevalence of ASD to be approximately 59 per 10,000. ASD affects males more often than females (ratio 4:1). Although ASD is conceptualized as a neurodevelopmental disorder, the symptoms and associated comorbid conditions (eg, anxiety, depression, inattention) are often lifelong. The precise neuropathology of ASD is unknown; however, a number of brain regions have been implicated, including the frontal cortex, cerebellum, and amygdala. Optimal treatment often combines intensive early-intervention behavioral strategies and pharmacological interventions.(C) 2006 American Academy of Neurology
|
|
diagnosis and treatment of postconcussive neurobehavioral symptoms.
- Kile, Shawn
>
Show/Hide Abstract
Postconcussive syndrome is a prevalent disorder composed of both neurological and psychiatric symptoms. Both neurologists and psychiatrists should be familiar with the variety of symptom complexes as well as appropriate treatment strategies aimed at improving the targeted symptoms without worsening others. This chapter will provide a review of postconcussive syndrome with a particular focus on the diagnosis and treatment of neurobehavioral sequelae.(C) 2006 American Academy of Neurology
|
|
psychiatric comorbidity in parkinson's disease, multiple sclerosis, and seizure disorders.
- Servis, Mark
>
Show/Hide Abstract
Psychiatric comorbidities of Parkinson's disease, multiple sclerosis, and seizure disorders include depression, anxiety, psychosis, and behavioral problems. They are common complications of both diagnosis and treatment. Shared symptoms of psychiatric comorbidity and neurological illness make identification of psychiatric illness challenging and suggest common underlying pathophysiology for some symptoms. Diagnosis and management of comorbid psychiatric illness should include consideration of multiple causes, including the neurological illness itself, primary psychiatric disorders, side effects of treatment, and other environmental and psychological factors. Treatment of neurological illness is a frequent cause of psychiatric comorbidity and complicates the management of comorbid anxiety, depression, and psychosis. Careful selection and dosing of psychotropic medication can avoid worsening neurological symptoms. Psychotherapy and social support provide effective adjunctive treatment.(C) 2006 American Academy of Neurology
|
|
somatization-an overview for neurologists.
- McCarron, Robert, Han, Jae, Motosue-Brennan, Julie
>
Show/Hide Abstract
Neurologists frequently encounter patients with inexplicable, unintentionally produced somatic complaints, otherwise known as somatoform disorders. Illness with excessive somatic preoccupation is difficult to diagnose or categorize reliably due to rigid diagnostic criteria that often overlap with several psychiatric disorders. Management of patients with dysfunctional somatoform disorders is complex and challenging, particularly when initiated in a neurology outpatient or inpatient setting. The acronym CARE-MD represents a comprehensive treatment regimen that can be used to decrease physician and patient frustration, dramatically minimize health care overutilization, and improve overall well-being for patients with somatoform disorders.(C) 2006 American Academy of Neurology
|
|
ethical perspectives in neurology.
- Russell, James
|
|
appendix a: practice parameter: the management of concussion in sports.
(PDF only)
|
|
appendix b: practice parameter: evaluation of the child with global developmental delay.
(PDF only)
|
|
index.
(PDF only)
|
|
multiple-choice questions.
|
|
patient management problem.
- Chang, Celia, Bourgeois, James
|
|
preferred responses.
|
The AAN is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical
education (CME) for physicians.
The AAN designates this educational activity for a maximum of 10 American Medical Association (AMA) Physician Recognition Award
(PRA) Category 1 Credits™. Physicians should claim only those hours of credit that they actually spend in the educational activity.
Per AMA PRA guidelines, only US and licensed international physicians may be awarded AMA PRA Category 1 Credit certificates. The
AAN will issue certificates of participation to non-MD/DO health professionals indicating that the activity was designated
for AMA PRA Category 1 Credit.
The American Board of Psychiatry and Neurology has reviewed
Continuum: Lifelong Learning in Neurology® and has approved the product as part of a
comprehensive lifelong learning program, which is mandated by the American Board of Medical Specialties
as a necessary component of maintenance of certification.
Andrea Weiss
Associate Publisher, AAN Enterprises, Inc.
Managing Editor, Continuum and Quintessentials
aweiss@aan.com
(651) 695-2742
|
|
